Log in
RegisterFixed Dose Combination Products [Design Issues]
Dear colleagues,
Is it possible to apply scaled ABE on one active drug ingredient identified as a highly variable drug/drug product based on a previous study and on published literature, but make use of the conventional ABE approach for the other active drug component identified as not highly variable? Of course this will be stated a priori in the protocol. Your insight on this would be appreciated. Thanks.
Is it possible to apply scaled ABE on one active drug ingredient identified as a highly variable drug/drug product based on a previous study and on published literature, but make use of the conventional ABE approach for the other active drug component identified as not highly variable? Of course this will be stated a priori in the protocol. Your insight on this would be appreciated. Thanks.
Complete thread:
- Fixed Dose Combination Productsjoyjac 2007-03-23 08:47
![[Mix]](https://static.bebac.at/img/mix.png "open in Mix view")
- Fixed Dose Combination Products Helmut 2007-03-23 11:27
Ing. Helmut Schütz